Depreciation in USD of Achilles Therapeutics plc from 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Achilles Therapeutics plc quarterly/annual Depreciation history and change rate from 2019 to Q2 2024.
  • Achilles Therapeutics plc Depreciation for the quarter ending 30 Jun 2024 was $1.2M, a 7.69% decline year-over-year.
  • Achilles Therapeutics plc annual Depreciation for 2023 was $4.7M, a 27% increase from 2022.
  • Achilles Therapeutics plc annual Depreciation for 2022 was $3.7M, a 12.1% increase from 2021.
  • Achilles Therapeutics plc annual Depreciation for 2021 was $3.3M, a 313% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.2M -$100K -7.69% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024
Q2 2023 $1.3M +$400K +44.4% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024
Q2 2022 $900K 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.7M +$1M +27% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024
2022 $3.7M +$400K +12.1% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024
2021 $3.3M +$2.5M +313% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024
2020 $800K +$500K +167% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 $300K 01 Jan 2019 31 Dec 2019 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.